Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



DRACHMAN JONATHAN G Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $2.01, valued at $20.4k
02/14/2022 5 DRACHMAN JONATHAN G (President and CEO) has filed a Form 5 on Neoleukin Therapeutics, Inc.
11/10/2021 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.
Txns: Bought 200,000 shares @ $0.8595, valued at $171.9k
08/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2021 4/A DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $0
05/07/2021 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $22.5, valued at $228.8k
08/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2020 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.
Txns: Granted 20,000 options to buy @ $5.25, valued at $105k
06/01/2020 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $20.59, valued at $209.3k
Granted 2,880 options to buy @ $20.59, valued at $59.3k
12/27/2019 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
12/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2019 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/04/2019 4 DRACHMAN JONATHAN G (See Remarks) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 1,650,000 options to buy @ $2.8, valued at $4.6M
08/12/2019 4 DRACHMAN JONATHAN G (President and CEO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 334,428 shares @ $0
Granted 7,428 shares @ $0
08/12/2019 3 DRACHMAN JONATHAN G (President and CEO) has filed a Form 3 on Neoleukin Therapeutics, Inc.
06/05/2019 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $11.84, valued at $120.4k
06/03/2019 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.
Txns: Granted 11,000 options to buy @ $5.42, valued at $59.6k
03/29/2019 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 4,266 options to buy @ $14, valued at $59.7k
02/07/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/04/2018 4 DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.
Txns: Granted 11,000 options to buy @ $5.15, valued at $56.7k
03/22/2018 4 DRACHMAN JONATHAN G (See Remarks) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 10,526 options to buy @ $34.2, valued at $360k
03/22/2018 4 DRACHMAN JONATHAN G (CMO & EVP, R & D) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Exercised 6,468 options to buy @ $15.46, valued at $100k
Exercised 3,831 options to buy @ $26.1, valued at $100k
Exercised 7,000 options to buy @ $10.61, valued at $74.3k
Exercised 13,740 options to buy @ $12, valued at $164.9k
03/07/2018 4 DRACHMAN JONATHAN G (CMO & EVP, R & D) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 7,200 shares @ $52.7, valued at $379.4k
Sold 3,257 shares @ $53.12, valued at $173k
Exercised 7,200 options to buy @ $8.96, valued at $64.5k
Exercised 3,257 options to buy @ $8.96, valued at $29.2k
01/16/2018 4 DRACHMAN JONATHAN G (CMO & EVP, R & D) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Exercised 6,260 options to buy @ $12, valued at $75.1k
Exercised 13,156 options to buy @ $10.61, valued at $139.6k
10/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy